Add BrightSurf on Google Email

Technical University of Munich (TUM)


Proof that a gut-wrenching complaint -- irritable bowel syndrome -- is not in your head

Biologists at TUM have discovered mini-inflammations in the gut mucosa that upset the balance of the bowel and cause IBS symptoms. The team's research suggests that treating IBS with antihistamines may improve symptoms by normalizing nerve activity. Successful identification of physical causes could lead to effective treatments for IBS.

SourceTechnical University of Munich (TUM)·JournalGASTROENTEROLOGY·DateAug 19, 2010

Minilab can quickly identify antibiotic residues in milk, before it leaves the barn

A fully automated minilab developed by Munich researchers can quickly identify antibiotic residues in milk, providing a fast and simple solution to the current laborious and expensive testing method. The system takes just under six minutes to produce a result, reducing production losses and disposal costs for the dairy industry.

SourceTechnical University of Munich (TUM)·JournalBiosensors and Bioelectronics·DateMay 7, 2010

Biophysicists manipulate 'zipper,' reveal protein folding dynamics

Researchers at TUM have successfully manipulated a single 'zipper' protein molecule to map changes in its energy landscape during folding and unfolding. This breakthrough provides higher-resolution measurements of protein folding dynamics, shedding light on the chain of events leading from DNA coding to biological function.

SourceTechnical University of Munich (TUM)·JournalProceedings of the National Academy of Sciences·DateJan 18, 2010

Genetic discovery could break wine industry bottleneck, accelerate grapevine breeding

German researchers have uncovered new details about the heredity of Vitis varieties in cultivation today, potentially breaking a bottleneck in the progress of the wine industry. They discovered a double mutation that could lead to more accurate classification tools and effective marker-assisted breeding methods.

SourceTechnical University of Munich (TUM)·JournalJournal of Agricultural and Food Chemistry·DateSep 24, 2009

Fine-tuning an anti-cancer drug

Researchers at TUM have developed a custom-tailored anti-cancer drug by understanding the mechanism of proteasome inhibition, a promising approach to treating cancer. By analyzing the reaction pathway and producing variants of the bacteria-produced Salinosporamide A, they aim to create effective drugs with improved safety and efficacy.

SourceTechnical University of Munich (TUM)·JournalJournal of Medicinal Chemistry·DateAug 18, 2009

Nanoscale origami from DNA

Scientists at TUM and Harvard University have successfully programmed DNA to assemble into complex twisted and curved nanoscale shapes. The researchers report achieving precise control over the shape's curvature and twist, with potential applications in building miniaturized devices for biomedical applications.